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        Deletion of no longer needed or potentially 
harmful cells by apoptosis acts as an essential bar-
rier against a variety of diseases, including auto-
immunity and cancer (  1, 2  ). Apoptosis can be 
triggered either via the so-called extrinsic path-
way by ligation of   “  death receptors,  ”   which are 
members of the tumor necrosis factor receptor 
(TNF-R) family, with an intracellular   “  death 
domain  ”   (e.g., Fas/APO-1/CD95, TNF-R1, 
DR4, and DR5) or through the   “  mitochondrial  ”   
(also called   “  intrinsic  ”   or   “  Bcl-2  –  regulated  ”  ) 
pathway, which is induced by developmental 
cues, growth factor deprivation, or a range of 
cytotoxic stimuli and regulated by the inter-
actions between pro- and antiapoptotic members 
of the Bcl-2 protein family (  2  ). Members of the 
Bcl-2 family are characterized by structural mo-
tifs, called Bcl-2 homology (BH) domains. The 
prosurvival family members Bcl-2, Bcl-x  L  , Bcl-
w, A1/Bfl  -1, and Mcl-1 contain up to four BH 
domains (BH1  –  4), whereas proapoptotic Bax, 
Bak, and Bok (Mtd) possess three BH domains 
(BH1, BH2, and BH3), and the BH3-only 
proteins possess only the BH3 domain (  1  ). 
  The BH3-only proteins Bik/Blk/Nbk, Bid, 
Bad, Hrk/DP5, Noxa/Apr, Bcl-2  –  modifying 
factor (Bmf), Puma/Bbc3, and Bim/Bod can all 
induce cell death when overexpressed in cells 
in tissue culture (  2  ). Induction of apoptosis by 
BH3-only proteins requires Bax or Bak (  3, 4  ), 
but how these proteins induce cell death is 
still not entirely clear. According to one model, 
certain BH3-only proteins (Bim, caspase-acti-
vated tBid, and perhaps Puma) activate Bax/Bak 
by direct binding, whereas the other BH3-only 
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  Members of the Bcl-2 protein family play crucial roles in the maintenance of tissue ho-
meostasis by regulating apoptosis in response to developmental cues or exogenous stress. 
Proapoptotic BH3-only members of the Bcl-2 family are essential for initiation of cell 
death, and they function by activating the proapoptotic Bcl-2 family members Bax and/or 
Bak, either directly or indirectly through binding to prosurvival Bcl-2 family members. Bax 
and Bak then elicit the downstream events in apoptosis signaling. Mammals have at least 
eight BH3-only proteins and they are activated in a stimulus-specifi  c, as well as a cell 
type  –  specifi  c, manner. We have generated mice lacking the BH3-only protein Bcl-2  –
  modifying factor (Bmf) to investigate its role in cell death signaling. Our studies reveal that 
Bmf is dispensable for embryonic development and certain forms of stress-induced apopto-
sis, including loss of cell attachment (anoikis) or UV irradiation. Remarkably, loss of Bmf 
protected lymphocytes against apoptosis induced by glucocorticoids or histone deacetylase 
inhibition. Moreover,   bmf        /      mice develop a B cell  –  restricted lymphadenopathy caused by 
the abnormal resistance of these cells to a range of apoptotic stimuli. Finally, Bmf-defi  -
ciency accelerated the development of      irradiation  –  induced thymic lymphomas. Our 
results demonstrate that Bmf plays a critical role in apoptosis signaling and can function as 
a tumor suppressor. 642 BMF IS REQUIRED FOR NORMAL B CELL HOMEOSTASIS | Labi et al.
certain cell types (  11, 12  ). Lymphocytes and certain other cell 
types from mice lacking   puma   are refractory to p53-induced 
apoptosis triggered by DNA damage. Interestingly, some 
p53-independent pathways to apoptosis, such as those trig-
gered by cytokine deprivation or treatment with glucocorti-
coids or phorbol esters, also rely on Puma (  13  –  15  ). Loss of 
Bim protects lymphoid cells against cytokine deprivation, 
deregulated Ca  2+  -fl   ux, and also glucocorticoids, indicating 
some functional overlap between Bim and Puma (  9, 16  ). 
In addition, Bim defi  ciency interferes with the deletion of 
autoreactive T and B cells (  17  –  19  ) and impairs the death of 
antigen-activated T cells during shutdown of an acute immune 
response (  20, 21  ). 
  Little is known about the physiological role of Bmf, 
which shares certain features with Bim. For example, both 
proteins were reported to interact with dynein light chain 
(DLC) molecules, small components of cytoskeleton-associ-
ated motor complexes such as the microtubule-based dynein 
motor complex containing DLC1, or the actin-based myosin 
V motor complex, containing DLC2. DLC1 was reported to 
sequester Bim to the microtubular dynein motor complex, 
whereas DLC2 targets Bmf to the actin-bound myosin V 
motor complex (  22, 23  ). In response to certain apoptotic 
stimuli, Bim and/or Bmf can be released from the cytoskeleton, 
translocate to mitochondria, and neutralize Bcl-2 prosurvival 
molecules to trigger Bax/Bak activation and caspase-mediated 
cell killing. UV irradiation, for example, causes release of 
both proteins, whereas Bmf seems to be specifi  cally activated 
in response to loss of cell attachment, a death stimulus that is 
proteins promote apoptosis by binding and neutralization of 
the prosurvival Bcl-2 family members (  5  ). The competing 
model proposes that BH3-only proteins activate apoptosis by 
binding only to the prosurvival Bcl-2  –  like proteins, thereby 
liberating Bax and Bak (  6  ). BH3-only proteins are thought to 
diff  er in their apoptotic potency because they diff  er in their 
ability to bind to the prosurvival Bcl-2 family members. For 
example, Bim and Puma bind all Bcl-2  –  like prosurvival pro-
teins with high affi   nity, whereas Noxa binds only Mcl-1 and 
A1 and, conversely, Bmf and Bad bind only to Bcl-2, Bcl-x  L  , 
and Bcl-w (  7, 8  ). 
  The roles of BH3-only proteins in normal physiology and 
stress-induced apoptosis have been addressed by gene target-
ing in mice. Deletion of any single BH3-only gene does not 
markedly perturb embryonic development, with the excep-
tion of Bim loss, which causes the death of   >  40% of embryos 
before embryonic day 10 (unpublished data) (  9  ). These and 
other observations indicate an extensive degree of functional 
redundancy between BH3-only proteins, and this was for-
mally demonstrated by the fi  nding that   bim        /       bik        /      males 
have severe defects in spermatogenesis, whereas males lacking 
only Bim or Bik are normally fertile (  10  ). Interesting cell 
type  –   and death stimulus  –  specifi  c defects have been observed 
in some knockout mouse strains lacking individual BH3-only 
proteins (  1  ). For example, loss of Bid renders hepatocytes 
resistant to anti-Fas antibody  –   or FasL-induced apoptosis, 
whereas lymphoid cells remain normally sensitive, demon-
strating that the Bid-mediated connection between the ex-
trinsic and the intrinsic apoptotic pathway is only critical in 
    Figure 1.         Generation of   bmf      /        mice by homologous recombination.   (A) Schematic representation of the   bmf   gene locus on mouse chromosome 2. 
Exons 3 and 4, as well as the neomycin selection marker, were fl  anked by   loxP   elements in the targeting construct. Exons 3 and 4, as well as the neomycin 
selection marker cassette, were removed in vivo by cre-mediated deletion using   Ubi-cre   deleter mice (dashed lines). The location of the 5     and  3    probes 
used for Southern blot analysis are indicated as black bars. (B) Southern blot analysis of liver-derived DNA from WT,   bmf  +/      , and   bmf     /       mice using 5    
and 3     external probes. (C) Analysis of   bmf   mRNA expression in MEFs by Northern blot analysis. (D) Bmf protein expression analysis by Western blotting in 
extracts from thymus, spleen, or lymph nodes derived from WT and both strains of Bmf-defi  cient mice, which had been generated from independent ES 
cell  clones.   JEM VOL. 205, March 17, 2008 
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using Bmf-specifi  c monoclonal antibodies. Our analysis re-
vealed that Bmf expression was highest in immature CD4  +  8  +   
(DP) thymocytes, but comparatively lower in mature resting 
T cells or mitogen-stimulated T cell blasts (  Fig. 2 A  ).   Bmf 
expression was found throughout B cell development with 
one notable exception: pro  –  B cells (  Fig. 2 A  ). Interestingly, 
expression of Bim was also detected from the pre  –  B cell stage 
onward and appeared strongest in CD4  +  8  +   thymocytes and 
CD8  +   T cells (  Fig. 2 A  ). Loss of Bmf did not cause   compensatory 
called anoikis (  22, 23  ). In addition, studies with certain tumor-
derived cell lines have indicated that Bmf is critical for killing 
of these cells induced by treatment with histone deacetylase 
inhibitors (HDACi) (  24  ). Interestingly, the   bim   and   bmf   genes 
are located near each other on mouse chromosome 2 and 
on syntenic regions on human chromosome 2 and 15, re-
spectively. This indicates that these genes may have arisen 
from a common ancestral BH3-only gene, although their 
homology today is restricted to the BH3 domain and DLC-
binding motif. Importantly, human chromosome 15q14, the 
region where the Bmf gene resides, was reported to harbor a 
so far unidentifi  ed tumor suppressor that is frequently lost 
during the very late stages in breast and lung cancer develop-
ment (  25, 26  ). 
  To investigate the role of Bmf in normal development and 
physiology, we have generated mice lacking   bmf  . The analysis 
of these animals revealed so far unidentifi  ed roles for Bmf in 
lymphocyte apoptosis, B cell homeostasis, and suppression of 
     irradiation  –  induced thymic lymphoma development. 
    RESULTS   
  Generation of Bmf-defi  cient mice 
  Our gene targeting approach was designed to remove exons 
3 and 4 of   bmf  , which contain the start codon and the BH3-
domain, respectively (  Fig. 1 A  ).   Correct targeting of the   bmf   
gene locus was confi  rmed by Southern blot analysis of geno-
mic DNA from embryonic stem (ES) cells (not depicted) and 
liver of knockout mice, using 5    and 3    external probes (  Fig. 1, 
A and B  ). Absence of   bmf   mRNA was verifi  ed by Northern 
blot analysis of polyA  +   mRNA from mouse embryonic fi  -
broblasts (MEFs;   Fig. 1 C  ), and the absence of the protein 
was confi  rmed in lysates from spleen, lymph nodes, and thy-
mus of animals from two independently derived knockout 
lines using a Bmf-specifi  c monoclonal antibody (  Fig. 1 D  ). 
Consistent with a previous study from human cells (  27  ), 
these tissues express two or three distinct Bmf isoforms; im-
portantly, all Bmf isoforms were deleted by our gene-target-
ing approach. 
  Analysis of heterozygous intercrosses of   bmf    +/      mice re-
vealed that Bmf-defi  cient animals were born at the expected 
Mendelian frequency, indicating that Bmf is dispensable for 
embryonic development. Animals lacking Bmf did not dis-
play any obvious phenotypic abnormalities, gender bias, or im-
paired fertility. Finally, histological examination of heart, lung, 
liver, kidney, and testis derived from 6  –  8-wk-old animals did 
not reveal any gross abnormalities (unpublished data). 
  Bmf is critical for glucocorticoid- and HDAC inhibitor  –
  induced thymocyte apoptosis 
  Bmf proteins are expressed at signifi  cant levels in hemopoi-
etic tissues (  Fig. 1 D  ), but it was not clear which cell types do 
express Bmf. Therefore, immature CD4  +  8  +   thymocytes, ma-
ture T and B cells from the spleen, B cell precursors from 
bone marrow, and T and B cell blasts generated by stimula-
tion of splenocytes with ConA or LPS, respectively, were 
isolated by FACS sorting and subjected to Western blotting 
    Figure 2.         Expression analysis of Bmf and Bim in different leukocyte 
subsets.   (A) Cells of the indicated differentiation stages were isolated 
from WT mice by cell surface marker staining and FACS sorting. Cells were 
lysed, and proteins were size fractioned by SDS-PAGE and transferred 
onto nitrocellulose membranes. Protein expression was evaluated using 
monoclonal antibodies recognizing mouse Bmf, Bim, or ERK (loading 
control). Membranes were stripped before subsequent reprobing with 
anti-Bim –   and  -ERK – specifi  c antibodies, respectively. (B) Total thymocytes 
and CD19  +   B cells from WT and   bmf     /       mice were analyzed for expression 
of Bim, Bad, and Puma. Reprobing with an anti-ERK  –  specifi  c antibody 
served as loading control. (C) B cell subsets of the indicated differentiation 
stages were isolated from WT or Bmf-defi  cient mice by cell surface marker 
staining and FACS sorting and processed as in A.     644 BMF IS REQUIRED FOR NORMAL B CELL HOMEOSTASIS | Labi et al.
up-regulation of other BH3-only proteins such as Bim, Bad, 
or Puma (  Fig. 2 B  ). 
  Next, we compared the overall leukocyte subset compo-
sition of primary and secondary lymphoid organs between 
6  –  8-wk-old WT and   bmf        /      animals. Bim-defi  cient animals 
show a well-defi  ned phenotype in the hemopoietic system 
(  9, 16  ) and were included in our analysis as a reference. Total 
thymic cellularity, as well as the percentages and overall num-
bers of all four major thymocyte subsets (CD4       8        double-
negative (DN), CD4  +  8  +   double-positive (DP), and CD4  +  8        
and CD4       8  +   single-positive (SP) cells were comparable be-
tween WT and Bmf-defi  cient animals (  Table I  ).   The per-
centages and numbers of cells expressing low or high levels of 
T cell receptor (TCR)      were also indistinguishable between 
mice of both genotypes (unpublished data). In contrast, Bim-
defi  cient animals displayed the previously described abnormal 
thymic cell subset composition (  9  ), which is characterized by 
reduced percentages and overall numbers of DP thymocytes 
and an accumulation of mature (TCR    /      +  ) DN and SP thy-
mocytes (  Table I  ). 
  To investigate a possible role for Bmf in stress-induced 
apoptosis, thymocytes from WT and Bmf-defi  cient animals 
were put in culture without further treatment (spontaneous 
death) or exposed to the phorbol ester PMA, the calcium ion-
ophore ionomycin, the DNA damage  –  inducing drug VP16, 
the glucocorticoid dexamethasone, the broad-spectrum kinase 
inhibitor staurosporin, the glycosylation inhibitor and ER 
stressor tunicamycin, or the histone-deacetylase inhibitors 
Trichostatin A, m-carboxycinnamic acid bis-hydroxamide 
(CBHA), or suberoylanilide hydroxamic acid (SAHA; also 
known as vorinostat). Responses to glucocorticoids and 
HDAC inhibitors were of particular interest because Bmf has 
previously been implicated in apoptosis induction of primary 
childhood leukemia cells by glucocorticoids (  28  ), as well as 
esophageal squamous cell carcinoma lines by CBHA (  24  ). 
Thymocytes from mice lacking Puma, which were previously 
shown to be resistant to spontaneous death, DNA damage, 
glucocorticoids and PMA (  13  ), were included as controls in 
these assays. Bmf-defi  cient thymocytes were normally sensitive 
to most apoptotic stimuli tested, including spontaneous death 
(  Fig. 3 A  ), but remarkably, they were abnormally resistant to 
VP16 (  Fig. 3 B  ), dexamethasone (  Fig. 3 C  ), and HDAC in-
hibition by SAHA (  Fig. 3 D  ).   Curiously,   bmf       /         thymocytes 
were almost as sensitive as WT cells to HDAC inhibition by 
CBHA or Trichostatin A (Fig. S1, A and B, available at http://
www.jem.org/cgi/content/full/jem.20071658/DC1). Con-
sistent with the inhibition of apoptosis, activation of caspase-3 
was delayed in   bmf       /         thymocytes treated with dexamethasone 
(  Fig. 3 E  ) or SAHA (  Fig. 3 F  ). In line with its relatively low 
expression in mature CD4  +   and CD8  +   T cells, loss of Bmf had 
no eff  ect on the response of these cells to any of the cytotoxic 
stimuli tested (unpublished data). Consistent with the observa-
tion that Bcl-2 overexpression does not protect lymphocytes 
against Fas-induced apoptosis (  29  ), loss of Bmf had no eff  ect on 
FasL-induced killing (unpublished data). In addition, assessment 
of the viability of thymocytes (mean viability WT 95.56% vs. 
    Figure 3.         Bmf-defi  cient thymocytes are abnormally resistant to 
certain apoptotic stimuli.   (A) Total thymocytes from mice of the indi-
cated genotypes were put in culture without further treatment (spontane-
ous death; A) or exposed to the DNA-damaging drug VP16 (etoposide; B), 
dexamethasone (C), or the HDAC inhibitor SAHA (D). Cell death was moni-
tored by Annexin V-FITC/PI staining and fl  ow cytometric analysis at the 
indicated time points. The extent of apoptosis induced specifi  cally by dif-
ferent stimuli was calculated by the following equation: (induced apopto-
sis      spontaneous cell death)/(100      spontaneous cell death). Means   ±   
the SEM from four independent experiments and   n   = 5 animals per geno-
type are shown. Signifi  cant differences in cell death induction were ob-
served between WT and Bmf-defi  cient cells treated with VP16 (P = 0.0096), 
dexamethasone (P = 0.0048), or SAHA (P = 0.0089) using ANOVA analysis. 
Thymocytes from WT and Bmf-defi  cient mice were evaluated for caspase-3 
activation in response to dexamethasone (E) or HDAC inhibition by SAHA 
(F) using an antibody specifi  cally recognizing the proteolytically generated 
active p17 fragment of caspase-3. Filters were reprobed using antibodies 
specifi  c for Bmf or     -actin (loading control). Reactivity of SAHA was con-
fi  rmed using an antibody recognizing acetylated histone H4 (Lys12) that 
was showing highest reactivity after 6 h. 8  –  10-wk-old female mice of the 
indicated genotypes were injected with graded doses of dexamethasone, 
and the percentages (G) and number (H) of surviving CD4  + 8 +   thymocytes 
were assessed 20 h later by cell counting of single-cell suspensions and 
fl  ow cytometric analysis of CD4 and CD8 cell surface marker expression. 
Bars represent the mean   ±   the SEM of 8 WT, 8   bmf     /     ,  and   ≥ 3   bim     /      
mice per treatment and   ≥  3 independent experiments. Using analysis of 
variance, signifi  cant differences (*) in the numbers of surviving thymocytes 
were observed between WT,   bmf     /      , and   bim     /       mice using 125   μ  g dexa-
methasone/mouse (P   <   0.04) and between WT and   bim     /       mice using 
500   μ  g dexamethasone (P = 0.007).     JEM VOL. 205, March 17, 2008 
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ered in   bmf       /         or   bim       /         mice 20 h after dexamethasone in-
jection were signifi  cantly larger than those found in WT animals 
(  Fig. 3, G and H  ). The extent of protection provided by Bmf 
defi  ciency was comparable to that aff  orded by the absence of 
Bim (  Fig. 3, G and H  ) or Puma (  30  ), indicating that gluco-
corticoids activate at least three BH3-only proteins to trigger 
cell death in mouse thymocytes. 
  Collectively, our data demonstrate that Bmf is dispensable 
for normal T cell development, but contributes to thymocyte 
apoptosis induced by certain cytotoxic stimuli, including treat-
ment with glucocorticoids or HDAC inhibitors. 
  bmf       /         95.96%;   n   = 4) or mature T cells (mean viability WT 
91.89% vs.   bmf       /         91.63%;   n   = 4) directly after organ harvest, 
by Annexin V/propidium iodide (PI) staining and fl  ow cytomet-
ric analysis, did not reveal any diff  erences in the steady-state 
level of T cell apoptosis in spleens and thymi from WT and 
  bmf       /         mice. 
  To examine the role of Bmf in apoptosis induction in 
vivo, we measured T cell depletion after injection of graded 
doses of dexamethasone and compared it to eff  ects observed 
in   bim       /         mice. Interestingly, the percentage (  Fig. 3 G  ) and 
number of CD4  +  8  +   thymocytes (  Fig. 3 H  ) that were recov-
  Table I.  Composition of primary and secondary lymphatic organs of Bmf-defi  cient mice 
Cell populations WT   bmf       /        bim       /      
Thymus
      Total cellularity (  ×  10  7  ) 26.56   ±   2.28 29.07   ±   2.44 22.47   ±   3.29
      CD4  +   cells  2.38   ±   0.19 1.94   ±   0.16 4.85   ±   0.81    a   
      CD8  +   cells  0.93   ±   0.08 0.84   ±   0.09 1.6   ±   0.23    a   
      CD4  +  8  +   cells  22.28   ±   2.02 25.25   ±   2.17 13.84   ±   2.13    a   
      CD4       8        cells  0.98   ±   0.1 1.03   ±   0.11 2.15   ±   0.28    a   
Bone marrow
      Total cellularity (  ×  10  6  ) 31.37   ±   2.4 40.19   ±   2.44    a   34.7    ±   2.63
      T cells 1.26   ±   0.15 1.45   ±   0.09 2.85   ±   0.31    a   
      Myeloid cells 12.91   ±   1.41 15.12   ±   1.42 9.73   ±   0.75
      Erythroid progenitors 12.13   ±   1.11 10.27   ±   0.82 6.78   ±   0.62    a   
      B cells 8.87   ±   1.15 15.57   ±   1.28    a   10.67    ±   0.93
      Pro B cells 1.61   ±   0.23 1.78   ±   0.11 2.61   ±   0.37    a   
      Pre B cells 4.66   ±   0.49 6.69   ±   0.52    a   4.94    ±   0.62
      T1 B cells 1.06   ±   0.19 1.86   ±   0.22    a   1.32    ±   0.43
      Mature B cells 1.73   ±   0.19 4.29   ±   0.48    a   4.07    ±   0.99    a   
Spleen 
      Total cellularity (  ×  10  7  ) 16.19   ±   1.42 26.1   ±   2.13    b   36.86    ±   3.32    a   
      CD4  +   T cells  2.76   ±   0.25 2.84   ±   0.24 5.12   ±   0.42    a   
      CD8  +   T cells  1.7   ±   0.3 2.01   ±   0.18 4.21   ±   0.41    a   
      Myeloid cells  1.1   ±   0.21 1.3   ±   0.17 1.07   ±   0.12
      Erythroid progenitors  1.67   ±   0.39 2.09   ±   0.36 3.59   ±   0.32    a   
      B cells  9.56   ±   0.98 18.79   ±   0.15    b   22.3    ±   2.13    b   
White blood cells
      Total cellularity (  ×  10  6  /ml) 8.76   ±   0.89 12.31   ±   0.91 22.4   ±   3.83    a   
      CD4  +   T cells  1.22   ±   0.26 0.96   ±   0.14 2.02   ±   0.31
      CD8  +   T cells  0.97   ±   0.2 0.84   ±   0.07 2.77   ±   0.38    a   
      Myeloid cells  1.56   ±   0.3 1.12   ±   0.13 1.41   ±   0.22
      B cells  5.71   ±   0.62 9.01   ±   0.79    a   16.25    ±   2.86    a   
      T1 B cells  0.51   ±   0.08 0.8   ±   0.1    a   1.47    ±   0.31    a   
Inguinal lymph nodes 
      Total cellularity (  ×  10  6  ) 9.75   ±   1.05 17.81   ±   1.47    a   21.25    ±   3.55    a   
      CD4  +   T cells  3.98   ±   0.51 5.44   ±   0.48 7.86   ±   1.09    a   
      CD8  +   T cells  2.67   ±   0.29 4.51   ±   0.42    a   11.99    ±   1.41    a   
      B cells  2.75   ±   0.58 7.7   ±   0.92    a   5.47    ±   0.97    a   
Total numbers of hemopoietic cells from 6  –  8-wk-old animals were calculated by counting single-cell suspensions derived from the indicated organs and tissues that were 
subsequently analyzed by fl  ow cytometry after staining for cell surface markers: total T cells (Thy-1  +  ), total myeloid cells (Mac-1  +  ), total nucleated erythroid progenitor cells 
(Ter119  +  ), total B cells (B220  + ),  pro – B  cells  (B220 + CD43 + IgM     ),  pre – B  cells  (B220 + CD43     IgM      ), T1 B cells (sIgM  high CD21 low  ), and mature B cells (sIgM  low IgD + ).  Numbers 
represent the mean (  ±   the SEM) of 6 WT, 9   bmf     /      , and 5   bim     /       mice. Total cellularity of both inguinal lymph nodes and femora are presented.
  a  P   <   0.05 compared to WT mice.
  b  P   <   0.0001 compared to WT mice.646 BMF IS REQUIRED FOR NORMAL B CELL HOMEOSTASIS | Labi et al.
bers was evident in the bone marrow of Bmf-defi  cient mice, 
whereas pro  –  B cell numbers were normal (  Table I  ). In con-
trast, pre  –  B cell numbers appeared normal in Bim-defi  cient 
animals (  Table I  ), although Bim is expressed in this cell subset 
(  Fig. 2  ). Shortly before immature B cells leave the bone mar-
row to continue their maturation in the spleen, the expression 
level of sIgM increases. T1 B cells were also abnormally ele-
vated in   bmf        /      mice (  Table I  ), as were those of recirculating 
  Bmf defi  ciency perturbs B cell homeostasis 
  Because Bmf protein expression was readily detectable at various 
stages of B cell development (  Fig. 2  ), we quantifi  ed the numbers 
of pro  –  B (B220  +  sIgM       CD43  +  ), pre  –  B (B220  +  sIgM       CD43       ), 
and transitional (T1) B cells (sIgM  high  CD21  low  ) in WT,  bmf       /        , 
and, as a control,   bim       /         mice, which are known to have de-
fects in developmentally programmed death of B lymphocytes 
(  9, 19  ). A signifi  cant (P   <   0.05) increase in pre  –  B cell num-
    Figure 4.         Loss of Bmf causes B cell hyperplasia.   (A) Flow cytometric analysis of spleen-derived single-cell suspensions from WT,   bmf     /      , and   bim     /      
mice using antibodies against the T cell marker Thy1 and the B cell marker B220. Representative dot blots of spleen cells stained with different B cell mat-
uration markers to identify different stages of B cell development: T1 transitional B cells (sIgM  high CD21 +  ); T2 transitional B cells (CD21  + CD23 + sIgM high ); 
mature follicular (FO) B cells (CD21  + CD23 +  ); marginal zone (MZ) B cells(CD21  high CD21     ); and plasma cells (PC; B220  + CD138 +  ). (bottom) Quantifi  cation of 
B cell subsets in the spleens derived from T,   bmf     /      , and   bim     /       mice  (n = 4) gathered in two independent experiments. Error bars represent the means   ±   
the SEM. Using the unpaired Student  ’  s   t   test,  signifi  cant differences between WT and   bmf     /       or   bim     /       mice were observed in T1 cells (P   <   0.039), T2 cells 
(P   <   0.0019), and FO cells (P   <   0.01). The number of plasma cells was only signifi  cantly elevated in Bim-defi  cient mice (WT vs.   bim     /     ;  P   <   0.03).   JEM VOL. 205, March 17, 2008 
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  To investigate possible consequences of the B cell excess 
observed in Bmf-defi  cient mice, we measured serum Ig levels 
in 8  –  10-wk-old mice and in animals challenged with anti-
gen. Total serum Ig levels were signifi  cantly (P   <   0.0123) el-
evated in   bmf        /      mice, but this diff  erence was no longer 
evident in aged (1-yr-old) animals (  Fig. 5  ). Thus, Bmf defi  -
ciency may enhance development and/or survival of plasma 
cells at a young age, and this is consistent with the mildly ele-
vated numbers of B220  +  CD138  +   plasma cells found in spleens 
of young   bmf       /         mice (  Fig. 4 E  ). To test whether   bmf       /         
mice are able to mount normal immune responses, we chal-
lenged WT and Bmf-defi  cient mice with T cell  –  dependent 
mature IgM  +  IgD  high   B cells. The numbers of these two B 
lymphoid populations were also abnormally elevated in Bim-
defi  cient mice, although only the increase in mature B cells 
was statistically signifi  cant (  Table I  ). Collectively, these re-
sults indicate that not only Bim but also Bmf regulates the 
developmentally programmed death of B lymphoid cells. 
  Cell counting revealed a   >  50% increase in the overall 
splenic cellularity in Bmf-defi  cient mice and, as shown before 
(  9  ), an     2  –  3-fold increase in   bim       /         mice (  Table I  ). Immu-
nofl  uorescent staining with surface marker  –  specifi  c antibodies 
and fl  ow cytometric analysis revealed that the percentage of 
B220  +   B cells was signifi  cantly increased in   bmf       /         mice, and 
that this increase was accompanied by a proportional decrease 
in the percentages of Thy1  +   T cells and Mac-1  +   myeloid cell 
(  Fig. 4 A   and not depicted).   This fi  nding was confi  rmed by 
staining splenocytes with antibodies recognizing the T cell 
markers CD4, CD8, or TCR     (unpublished data). The over-
all numbers of mature CD4  +   and CD8  +   T cells in   bmf       /         
mice were, however, comparable to those observed in WT 
mice, and their abnormally low percentages were a consequence 
of the abnormal B cell expansion. In contrast, and as previ-
ously shown (  9  ), excess numbers of both B and T lympho-
cytes were found in spleens of   bim        /      mice (  Table I  ). 
  Detailed analysis of diff  erent B cell maturation stages in the 
spleen (  Fig. 4, B and E  ) revealed signifi  cantly elevated numbers 
of T1 transitional B cells in   bmf       /         and   bim       /         mice and a pro-
found increase in T2 transitional B cells (CD21  +  CD23  +  sIgM  high  ), 
a subpopulation of sIgM  +  sIgD  +   B cells that can give rise to 
mature sIgM  low  sIgD  +   B cells in reconstitution experiments 
in   rag        /      mice (  31  ). Mature follicular B cells (CD21  +  CD23  +  ) 
were also abnormally increased in both   bmf       /         as well as   bim       /         
mice, but the numbers of marginal zone (MZ) B cells (CD-
21  high  CD23       ), a subset of B cells that lines the border of the 
white pulp and is critical for responses to type 2 thymus-inde-
pendent antigens, were normal (  Fig. 4 E  ). Loss of either Bmf 
or Bim also caused an abnormal increase in the numbers of 
mature B cells in inguinal lymph nodes, as well as an increase 
in the numbers of T1 B cells and mature B cells in the periph-
eral blood (  Table I  ). Interestingly, loss of Bim caused a more 
pronounced accumulation of B lymphoid cells in blood and 
spleen than Bmf defi  ciency but in inguinal lymph nodes the 
numbers of B cells were higher in   bmf       /         mice than in   bim        /      
mice (  Table I  ). 
  These results indicate that Bmf-defi  cient B cell progenitors 
and/or mature B cells may have a survival advantage leading to 
their accumulation, B cell hyperplasia, and possibly also B cell 
neoplasia in older mice. To examine this hypothesis, we fol-
lowed cohorts of WT and Bmf-defi  cient animals and assessed 
their B cell compartments at 12 mo of age. Consistent with 
our observations in young animals, spleens from Bmf-defi  cient 
animals were signifi  cantly increased when compared with 
spleens from age-matched WT or Puma-defi  cient animals 
(Table S1, available at http://www.jem.org/cgi/content/full/
jem.20071658/DC1). The lymphadenopathy in   bmf       /         mice, 
however, did not progress to B cell neoplasia, at least during 
our observation period of up to 18 mo (unpublished data). 
    Figure 5.         Mild hypergammaglobulinemia in untreated Bmf-defi  cient 
mice.   Ig-titers in the sera from 8  –  12 wk or 12-mo-old WT and   bmf     /      
mice were quantifi  ed by ELISA. Dilutions were predetermined to produce 
absorbance readings in the linear range. Total Ig 1:80.000 (A), IgM 
1:40.000 (B), IgG1 1:40.000 (C), IgG2a 1:4000 (D), IgG2b 1:80.000 (E), IgG3 
1:40.000 (F), and IgA 1:40.000 (G). Box plots represent values from   n   =  4 
WT and 8   bmf     /       mice (8  –  10 wk), and 8 WT and 8   bmf     /       aged  mice. 
Signifi  cant differences were only observed in the total Ig levels between 
young WT and Bmf-defi  cient mice using Student  ’  s   t   test (P   <   0.0123). 
(H) Autoantibodies to dsDNA were quantifi  ed in the sera from 8  –  12-wk- or 
12-mo-old mice by ELISA using ds calf thymus DNA for coating (serum 
dilution 1:100). Box plots represent values from   n   = 6 WT and 6   bmf     /      
mice (8  –  10 wk) and 5 WT and 8   bmf     /       aged  mice.   648 BMF IS REQUIRED FOR NORMAL B CELL HOMEOSTASIS | Labi et al.
ability WT 75.2   ±   3.4% vs.   bmf       /         82.8   ±   2.0%;   n   = 4) in the 
absence of Bmf. Interestingly, we observed that the percent-
age of BrdU  +   cycling pro  –  /pre  –  B cells was lower in the bone 
marrow of   bmf       /         mice (10.42   ±   2.42%) when compared 
with the relevant WT (16.35   ±   0.64%) control mice (  n   = 4; 
P = 0.008). However, in vitro proliferative responses of iso-
lated pre –  B cells stimulated with SCF and IL-7 or mature splenic 
B cells stimulated by anti-CD40 antibodies, BCR-ligation, 
LPS, or CpG were normal in the absence of Bmf (Fig. S6 and 
not depicted). 
  Collectively, these data indicate that loss of Bmf confers 
a survival advantage to B lineage cells in vivo and that the 
(NP-OVA) (Fig. S2 A, available at http://www.jem.org/cgi/
content/full/jem.20071658/DC1) and T cell  –  independent 
(TNP-Ficoll) antigens (Fig. S2 B). Quantifi  cation of antigen-
specifi  c Ig production did not reveal signifi  cant diff  erences 
compared with WT mice, although IgG2a levels appeared to 
be slightly elevated in sera from Bmf-defi  cient mice (  Fig. 2 D  ). 
To address the question whether loss of Bmf, similar to loss 
of Bim (  16  ), facilitates the survival of autoreactive B cells, we also 
monitored animals for the presence of dsDNA-specifi  c auto-
antibodies in sera from   bmf       /         mice. Loss of Bmf did not trig-
ger an accumulation of anti-dsDNA autoantibodies beyond 
the levels observed in age-matched WT mice (  Fig. 5 H  ).   
  Bmf is a critical regulator of apoptosis in pre  –  B cells 
  The B cell hyperplasia observed in Bmf-defi  cient mice may 
be caused by defects in apoptosis at early or late stages of B cell 
development. To investigate this possibility, we analyzed cell 
death responses of purifi  ed B cells from   bmf       /         and, for com-
parison,   puma       /         animals. Immature bone marrow  –  derived 
pre  –  B cells and splenic B cells were isolated by cell sorting, 
placed in culture, and exposed to a broad range of apoptotic 
stimuli, including cytokine withdrawal, treatment with the 
glucocorticoid dexamethasone, the broad-spectrum kinase 
inhibitor staurosporin, the DNA-damaging drug VP16, the 
glycosylation inhibitor and ER stressor tunicamycin, and the 
HDAC inhibitors Trichostatin A, CBHA, or SAHA, as well 
as B cell receptor (BCR) ligation with cross-linking anti-IgM 
antibodies. Cell viability was monitored over time by An-
nexinV-FITC/PI staining and fl  ow cytometric analysis. Pre-
B cells lacking Bmf were normally sensitive to spontaneous 
death in culture (  Fig. 6 A  ), as well as death induced by VP16 
(  Fig. 6 C  ) but highly refractory to dexamethasone (  Fig. 6 B  ), 
or HDAC-inhibition by SAHA (  Fig. 6 D  ).   B cells lacking 
Bmf, isolated from spleens by negative FACS-sorting (i.e., 
staining and depletion of T cells myeloid cells and erythroid 
cells) were as sensitive as WT cells to apoptosis induced by 
cytokine deprivation (Fig. S1 C), dexamethasone (Fig. S1 D), 
VP16 (Fig. S1 E), staurosporin, and tunicamycin (not de-
picted). Only SAHA-induced cell death showed delayed ki-
netics (Fig. S1 F). BCR ligation  –  induced apoptosis appeared 
somewhat delayed in the absence of Bmf, but this diff  erence 
was not statistically signifi  cant (Fig. S1 F). 
  To test whether the reduced sensitivity to GC treatment 
in vitro may be of relevance in vivo  ,   WT and Bmf-defi  cient 
mice were injected with graded doses of dexamethasone. 
Consistent with our in vitro observations, absence of Bmf 
provided pre  –  B cells with partial resistance to the eff  ects of 
systemic GC injection (  Fig. 6, E and F  ). Collectively, these 
results indicate that Bmf is critical for stress-induced apoptosis 
of pre  –  B cells, but appears to play only a modest or redun-
dant role for stress-induced killing of mature B cells. 
  Assessment of viability of bone marrow  –  derived pre  –  B cells 
or mature splenic B cells straight after organ harvest revealed 
slightly higher percentages of viable (Annexin V-FITC/PI-neg-
ative) pre  –  B cells (mean viability WT 78.8   ±   5.6% vs.   bmf       /         
89.1   ±   1.5%;   n   = 4) as well as mature IgM  +   B cells (mean vi-
    Figure 6.         Impaired cell death responses in   bmf      /        pre  –  B cells.  
FACS-sorted pre  –  B cells (B220  + sIgM     CD43      ) from mice of the indicated 
genotypes were put in culture without further treatment (A; spontaneous 
death) or exposed to dexamethasone (B), the DNA-damaging drug VP16 (C), 
or the HDAC-inhibitor SAHA (D). Cell death was monitored, and the 
extent of apoptosis induced specifi  cally by different stimuli was calcu-
lated as indicated in   Fig. 3  . Means   ±   the SEM from four independent 
experiments and   n   = 5 animals per genotype are shown. Signifi  cant 
differences in cell death induction were observed between WT and Bmf-
defi  cient cells treated with dexamethasone (P = 0.0001) or SAHA (P = 
0.004) using ANOVA analysis. Mice of the indicated genotypes were in-
jected with graded doses of dexamethasone and the percentage (E) and 
total number (F) of surviving pre  –  B cells was assessed 20 h later by cell 
counting of bone marrow single-cell suspensions and fl  ow cytometric 
analysis of pre  –  B cell surface marker expression (B220  + sIgM     CD43     ). 
Bars represent the means   ±   the SEM of   ≥  3 animals per genotype/dose 
(three independent experiments). Signifi  cant differences in vivo were 
observed between the number of surviving WT and Bmf-defi  cient pre 
B-cells in mice treated with 125   μ  g dexamethasone (P = 0.01).     JEM VOL. 205, March 17, 2008 
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irradiated hosts, some of the leukocyte subsets contained sig-
nifi  cantly more cells that were derived from   bmf       /         stem cells 
than from WT stem cells. Among the CD4  +   T lymphocytes 
and CD19  +   B lymphocytes in reconstituted hosts there was a 
clear predominance of cells of   bmf       /         origin (  Fig. 7, B and D  ). 
Numbers of Bmf-defi  cient CD8  +   T cells were, if anything, 
only slightly increased compared with CD8  +   cells of WT origin 
(  Fig. 7 C  ). Interestingly, a percentage signifi  cantly greater 
than the expected 50% of immature CD4  +  8  +   cells, as well as 
CD4  +  8        and CD4       8  +   T cells in thymi of reconstituted animals, 
were of   bmf       /         origin (  Fig. 7 E  ). Moreover, consistent with 
our fi  ndings in peripheral blood, the percentages of mature 
CD4  +   T cells and CD19  +   B cells lacking Bmf was signifi  -
cantly increased above the expected 50% in the spleen and 
lymph nodes (  Fig. 7 F   and not depicted). Collectively, these data 
demonstrate that absence of Bmf provides a signifi  cant cell 
autonomous survival advantage to the B linage cells and, to a 
lesser extent, to developing and mature T lymphocytes. 
  Bmf is not required for apoptosis induced by UV irradiation 
or cell detachment 
  As shown in   Fig. 1 C  ,   bmf   mRNA was detected in MEFs, and 
Bmf and Bim proteins were previously shown to be released 
from cytoskeletal sequestration in response to UV-irradiation or 
loss of integrin signaling during anoikis (  22, 23  ). To investigate 
accumulation of mature B cells in peripheral organs, caused by 
loss of Bmf, may cause a reduction in the proliferation of B cell 
precursors in the bone marrow as a negative feedback. 
  Bmf regulates B cell homeostasis in vivo 
  The observation that spontaneous death of immature and 
mature B cells in culture was not signifi  cantly diff  erent be-
tween WT and Bmf-defi  cient cells, whereas the percentage 
of viable cells appeared higher in   bmf       /         mice in vivo, made 
us wonder whether the observed B cell accumulation was 
caused by a cell-intrinsic apoptosis defect caused by loss of 
Bmf, or whether Bmf defi  ciency  –  induced changes in the mi-
croenvironment may be responsible for this phenomenon. 
Therefore, we set up competitive reconstitution experiments 
in which lethally irradiated congenic Ly5.1 recipient mice 
were reconstituted with a 50:50 mix of either WT Ly5.1 and 
Ly5.2 bone marrow cells or a 50:50 mix of WT Ly5.1 and 
  bmf       /        Ly5.2 bone marrow cells. Immunofl  uorescent staining 
and FACS analysis showed that WT and   bmf       /         mice had 
similar numbers of Lin       Sca-1  +  c-kit  +   cells in their bone mar-
row (mean WT 3.5 vs. 3.7%;   n   = 3). Hemopoietic reconsti-
tution was followed over time by assessing the percentages of 
Ly5.2  +   cells in the peripheral blood (  Fig. 7, A  –  D  ), and in 
thymus and spleen, reconstitution was assessed at a single 
time point, which was after 21 wk (  Fig. 7, E and F  ).   In the 
    Figure 7.         Bmf-defi  ciency promotes abnormally enhanced lymphocyte accumulation through a cell autonomous mechanism.   Ly5.1  congenic 
mice were reconstituted 6 h after lethal irradiation (10 Gy) using a 50:50 mixture of WT Ly5.1 + WT Ly5.2 or WT Ly5.1 +   bmf     /      Ly5.2 bone marrow cells 
(total 4   ×   10  6   cells/mouse). Reconstitution was monitored over time by evaluating the percentage of donor cells in peripheral blood by FACS analysis us-
ing a Ly5.2-specifi  c antibody, either alone (A) or in combination with the T cell markers CD4 (B), CD8 (C), or the B cell marker specifi  c antibody CD19 (D). 
21 wk after reconstitution, animals were killed and the percentage of donor-derived lymphocytes was assessed in thymus (E) and spleen (F) using the cell 
surface  marker – specifi  c antibodies indicated.     650 BMF IS REQUIRED FOR NORMAL B CELL HOMEOSTASIS | Labi et al.
the requirement of Bmf for pathways to apoptosis, we ex-
posed low-passage primary MEFs from WT mice or mice 
lacking the BH3-only proteins Bmf or Bim to graded doses 
of UV irradiation and analyzed survival over time in culture 
(Fig. S3, A and B). Annexin V-FITC/PI staining and fl  ow 
cytometric analysis of cells revealed that neither absence of 
Bmf nor Bim consistently prevented cell death in response to 
UV irradiation (Fig. S3, A and B). 
  Primary MEFs were subjected to anoikis by culturing 
them on poly-hema  –  coated plates, thereby preventing their 
attachment and simulating loss of contact to extracellular ma-
trix, in the presence or absence of serum. Loss of Bmf did not 
delay cell death by anoikis, regardless of serum conditions 
(Fig. S2, C and D). To confi  rm this fi  nding in a more physi-
ologically relevant setting we used diff  erentiated epithelial 
cells lining the gut lumen. Epithelial cells from the small and 
large intestine are expelled from the tip of villi at high fre-
quency and are subsequently replaced by new diff  erentiating 
cells derived from stem cells located at the basis of the crypts. 
Mature cells that are shed are thought to die by anoikis caused 
by lack of integrin signaling and/or loss of contact to the ex-
tracellular matrix (  32  ). Because we detected   bmf   mRNA ex-
pression in the colon (  23  ), we started to assess the role of Bmf 
in anoikis induction of gastrointestinal epithelial cells. Pri-
mary epithelial cells were isolated from the small intestine 
and/or colon of WT,   bmf       /        , or   bim       /         animals. Purity of 
the isolated cell suspensions was verifi  ed by intracellular stain-
ing for the epithelial cell marker cytokeratin using a pan-
cytokeratin  –  specifi  c antibody and fl  ow cytometric analysis 
(Fig. S4 A). Isolated cell suspensions derived from the small 
intestine routinely contained   >  80% epithelial cells, and those 
from the colon contained   >  90% epithelial cells (Fig. S4 A). 
Isolated epithelial cells were cultured in low attachment plates, 
and viability was monitored over time. Flow cytometric 
staining of DNA content (cells with a sub-G1 DNA content 
being considered apoptotic) and intracellular staining for ac-
tive caspase-3 demonstrated that epithelial cells undergo rapid, 
caspase-dependent apoptosis in vitro  .   However, this cell death 
was not attenuated in the absence of Bmf or Bim (Fig. S4 B). 
Statistical analysis of combined experiments on colonic epithelial 
cells (Fig. S4 C) or cells from the small intestine (Fig. S4 D) 
failed to reveal signifi  cant diff  erences between the genotypes, 
although cell death appeared somewhat delayed in colonic 
epithelial cells lacking Bim or Bmf. Collectively, our data show 
that Bmf and Bim are dispensable for anoikis of gastrointestinal 
epithelial cells. 
  Loss of Bmf enhances      irradiation  –  induced thymic 
lymphoma development 
  The human   BMF   gene is encoded on chromosome 15q14, a 
region that harbors a potential tumor suppressor that is fre-
quently lost during the late stages of lung and breast cancer (  25  ). 
    Figure 8.         Loss of Bmf enhances      irradiation induced thymic 
lymphoma development.   Mice of the indicated genotypes (7  –  8 wk of age) 
were exposed to whole body irradiation using 2.5 Gy. Animals were killed 
20 h later, and thymocyte numbers were evaluated by FACS analysis of 
cell surface marker expression (A) and cell counting to calculate the total 
number of thymocytes (B) and CD4  + 8 +   immature thymocytes (C). Bars 
represent means   ±   the SEM of 3 WT and 5 Bmf-defi  cient animals and two 
independent experiments. Signifi  cant differences in depletion of total 
thymocytes (P = 0.0044) and CD4  + 8 +   thymocytes (P = 0.003) were con-
fi  rmed using ANOVA analysis. Cohorts of WT (  n   = 16),   bmf     /       ( n   = 8), and 
  p53  +/       ( n   = 9) mice were exposed to a fractionated      irradiation  protocol 
(4   ×   1.75 Gy in weekly intervals, starting at 4 wk of age) and monitored 
for the development of thymic lymphomas over time. (B) Kaplan-Meier 
analysis of tumor-free survival of mice of the indicated genotypes. Log 
rank (Mantle-Cox) analysis was used to calculate differences between WT 
and   p53  +/       (P = 0.027) and WT and   bmf     /       mice (P = 0.009).     
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considered to depend mostly on Bim because loss of Bim can 
partially rescue the B cell lymphopenia caused by IL-7 or -7R 
defi  ciency (  34, 35  ). Interestingly, only the number of naive 
and recirculating mature B cells was signifi  cantly elevated in 
  bim       /         mice (  9, 36  ). However, the numbers of these B cell pop-
ulations were reported to be even higher in   vav-bcl-2 tg   mice 
(  16  ), suggesting that other BH3-only proteins besides Bim 
can also regulate the developmentally programmed death of 
these cells. It is interesting to note that B cell numbers in the 
bone marrow of   bim       /      puma       /         (  16  ),   bim       /      blk       /         (  10  ), or 
  bim       /      bad       /         (unpublished data) double-defi  cient mice do 
not exceed that observed in   bim       /         mice. This excludes over-
lapping functions for Bim with Puma, Blk, or Bad in the reg-
ulation of B cell apoptosis in the bone marrow, and indicates 
that Bmf is a likely candidate that may have overlapping 
functions with Bim in this process. Interestingly, pro  –  B cell 
numbers were the only B cell subset not aff  ected by the ab-
sence of Bmf, which is consistent with the lack of its expression 
in theses cells (  Fig. 2  ). Bmf was found to be expressed at high 
levels in all other B cell subsets investigated, but comparatively 
lower levels were found in mature splenic T cells (  Fig. 2 A  ), 
which is consistent with the fi  nding that the number of 
T cells was normal in the absence of Bmf (  Table I  ). 
  The splenomegaly observed in   bmf        /      mice was clearly 
less pronounced than that observed in   bim        /      animals be-
cause of the fact that loss of   bmf   caused only accumulation of 
B cells, but not T cells, whereas loss of Bim caused accumula-
tion of both cell types (  Table I  ). Consistent with our hypo-
thesis that Bim and Bmf co-regulate developmental death of 
B cells, the numbers of splenic B cells in   vav-bcl-2 tg   mice 
also clearly exceed those observed in Bim-defi  cient mice (  16  ). 
It will therefore be interesting to see whether compound 
mutants that lack both Bim and Bmf show a synergistic in-
crease in B cell numbers or other leukocyte subsets. 
Loss of Bmf interfered most potently with apoptosis in 
thymocytes and pre  –  B cells induced by glucocorticoids or 
inhibitors of histone-deacetylases. The fi  nding that   bmf       /         
lymphoid cells are abnormally resistant to glucocorticoid-in-
duced apoptosis is consistent with the observation that   bmf   
expression is induced by systemic application of dexametha-
sone in children suff  ering from acute lymphatic leukemia and 
in corresponding model cell lines in vitro (  28  ). The involve-
ment of Bmf in HDAC inhibitor  –  induced cell killing con-
fi  rms previously published data gathered in oral and esophageal 
squamous carcinoma cells, which suggested that Bmf may be 
rate limiting for the antineoplastic eff  ects of these drugs (  24  ). 
Surprisingly, cell death triggered by CBHA was only mildly 
delayed in   bmf       /         thymocytes and Trichostatin A induced 
cell death as potently as in WT cells (Fig. S1, A and B), arguing 
against a unifying cell death mechanism triggered by HDAC 
inhibitors, as suggested by others (  37  ). In contrast to published 
data, we were unable to observe a signifi  cant increase in Bmf 
protein expression after exposure to SAHA (  Fig. 3 F   and not 
depicted), demonstrating that increased Bmf expression is not 
a prerequisite to kill primary lymphocytes by this HDAC in-
hibitor. The diff  erences observed may be caused by changes 
To examine the tumor suppressor capacity of Bmf, we ex-
posed a cohort of WT,   bmf       /        , and   p53  +/         animals to a frac-
tionated      irradiation protocol and monitored the development 
of thymic lymphomas over time. Interestingly, loss of Bmf 
delayed cell death of thymocytes in response to      irradiation 
in vivo (  Fig. 8, A and B  ) and markedly accelerated the onset 
of thymic lymphomas to an extent comparable to the eff  ect 
caused by loss of one allele of   p53   (  Fig. 8 C  ).   The thymic 
lymphomas arising in   bmf       /         mice displayed either an imma-
ture CD4  +  8  +   or CD8  +   SP phenotype, with frequent infi  ltra-
tions of tumor cells seen in the spleen (Fig. S5). Our fi  ndings 
are consistent with the notion that BH3-only proteins can act 
as tumor suppressors, and they document a so far unknown 
role for Bmf in DNA damage-induced apoptosis and sup-
pression of thymic lymphoma development. 
    DISCUSSION   
  Studies on BH3-only protein knockout mice have started to 
unravel cell-type and death stimulus-specifi   c functions in 
apoptosis signaling for most members of this family. Loss of 
individual BH3-only proteins, with the exception of Bim (  9  ), 
is generally compatible with embryonic development sug-
gesting redundancy among these proteins in developmental 
cell death. In the adult organism, however, cell type- as well 
as death stimulus  –  specifi  c defects have been reported in some 
knockout mouse strains lacking individual BH3-only protein 
genes (  1  ). Bid-defi  cient mice, for example, resist Fas-mediated 
hepatocyte destruction, supporting its role as a link to and 
amplifi  er of the death receptor-signaling pathway (  11, 12  ). 
In contrast, lymphocytes and other cell types from mice lack-
ing   puma   show a profound defect in p53-induced apoptosis in 
response to DNA damage. Loss of Bim renders leukocytes 
refractory to the eff  ects of cytokine deprivation, deregulated 
Ca  2+  -fl  ux and glucocorticoids and strongly interferes with the 
deletion of autoreactive T and B cells (  17  –  19  ), as well as the 
proper termination of immune responses (  20, 21  ). Interestingly, 
Bim and Puma synergize in the mediation of many forms of 
cell death because lymphocytes from   bim       /      puma       /         mice resist 
p53-dependent and -independent forms of apoptosis more 
potently than cells from single knockout mice (  16  ). Moreover, 
although loss of   Blk   on its own does not cause any overt abnor-
malities, the combined loss of Blk and Bim leads to male in-
fertility caused by defects in spermatogenesis (  10, 33  ). 
  Our analysis of Bmf-defi   cient animals revealed several 
novel and unexpected fi  ndings. We found that Bmf is dis-
pensable for embryogenesis and organogenesis, which is con-
sistent with the observation in all other BH3-only knockout 
mouse models investigated thus far, with the exception of the 
partial embryonic lethality caused by loss of Bim. Surpris-
ingly, we noted that loss of Bmf specifi  cally causes a defect in 
B cell homeostasis, whereas T cell and myeloid cell develop-
ment and homeostasis were not aff  ected (  Table I  ). The num-
bers of bone marrow pre  –  B cells and transitional B cells were 
both found to be abnormally elevated in Bmf-defi  cient ani-
mals (  Table I  ). So far, the death of B cell progenitors in the 
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inhibition of Bim through MAPK-mediated proteasomal 
degradation (  42, 43  ). It has, however, been argued that Bim 
primarily senses the loss or lack of EGF-R  –  mediated ERK 
activation and that loss of integrin signaling may activate 
other proapoptotic molecules besides Bim (  44, 45  ). Bmf was 
a good candidate for such a molecule because it changes its 
subcellular localization in MCF-7 cells that were forced to 
undergo anoikis (  23  ). However, our analysis of primary MEFs 
and gastrointestinal epithelial cells derived from the small in-
testine or colon did not support a rate-limiting role for Bmf 
or Bim in this process. This does not exclude a role for either 
protein in anoikis of primary mammary epithelial cells, as 
previously suggested (  46  ), or in transformed cell lines (  23  ). 
  The fact that loss of Bmf accelerated thymic lymphoma-
genesis triggered by repeated      irradiation is consistent with 
its proposed role as tumor suppressor (  23  ). The fact that Bmf 
defi  ciency can also delay      irradiation  –  induced apoptosis in 
thymocytes is surprising because we did not fi  nd evidence 
that   bmf   is induced in response to DNA damage (unpublished 
data). However, similar observations have been made in 
Bim-defi  cient mice (  30  ). Our fi  ndings suggest that Bmf may 
act in a parallel p53-independent pathway to apoptosis that is 
activated by DNA damage, or that it may be activated by la-
tent oncogenic stress subsequent to the pathological response 
to DNA damage. 
  Collectively, our investigations have revealed a promi-
nent role for Bmf in lymphocyte apoptosis induced by gluco-
corticoids and HDAC inhibitors, as well as a role as tumor 
suppressor. In addition, our data indicate that Bmf acts in 
concert with Bim to regulate B cell homeostasis and lympho-
cyte apoptosis, and investigations on animals lacking Bim and 
Bmf are underway to examine this. 
    MATERIALS AND METHODS   
  Generation of Bmf-defi  cient mice and other mouse strains used.     All 
animal experiments were performed in accordance with the Austrian 
  “  Tierversuchsgesetz  ”   (BGBl. Nr. 501/1988 i.d.g.F) and have been granted 
by the Bundesministerium f  ü  r Bildung, Wissenschaft und Kultur (bm:bwk) 
or were performed according to the guidelines of the Melbourne Directorate 
Animal Ethics Committee. The generation and genotyping of the Puma- 
and Bim-defi  cient mice has been previously described (  9, 13  ). The   puma       /         
mice were generated on an inbred C57BL/6 genetic background using 
C57BL/6-derived ES cells. The   bim       /         mice were originally generated on a 
mixed C57BL/6   ×   129SV genetic background, using 129SV-derived ES 
cells, and they were subsequently backcrossed onto the C57BL/6 background 
for at least 12 generations. 
  To generate a   bmf  -targeting construct, C57BL/6 genomic DNA was 
isolated and subcloned from the RPCI-23 BAC clone # 266K3 (Roswell 
Park Cancer Institutes, Roswell Park, NY), harboring the entire   bmf   locus 
(  Fig. 1  ). After electroporation and selection of C57BL/6-derived Bruce4 ES 
cells, two out of three homologous recombined clones were injected into 
BALB/c blastocysts and delivered by CD1 surrogate mothers to generate 
chimeric mice. Heterozygous off  spring of subsequent mating of chimeric 
males, which were derived from two independent ES cell clones, with 
C57BL/6 females were used to establish the   bmf   f/+     mouse lines, designated 
372 and 376, containing a fl  oxed   bmf  -allele. The neomycin resistance cas-
sette and exons 3 and 4 of the   bmf   gene (  Fig. 1 A  ) were subsequently deleted 
by crossing to female C57BL/6   ubi-cre   deleter mice to establish the substrains 
372del and 376del. These animals were further backcrossed with C57BL/6 
in   bmf  -gene accessibility in primary versus transformed cells. 
In malignant cells,   bmf   may be silenced epigenetically, a pos-
sibility that may be relevant here because the   bmf   gene con-
tains a well-defi  ned CpG island in its promoter region (  24  ).
  The basis for the abnormal accumulation of pre  –  B cells 
and mature B cells in the absence of Bmf is unclear at present. 
Bmf as a target for BCR or cytokine receptor signaling does 
not appear to be a likely explanation because application of 
IL-7 or BAFF potently extended the survival of pre  –  B and 
mature B cells, respectively (not depicted). Moreover, BCR 
ligation-induced apoptosis was normal in the absence of Bmf 
(Fig. S1 F). On the other hand, the apoptosis defect of lym-
phocytes appears to be cell intrinsic, as documented in our 
reconstitution experiments (  Fig. 6  ). We also excluded enhanced 
proliferation potential of Bmf-defi  cient B cells in response to 
mitogens as a possible explanation for the observed B cell hy-
perplasia (Fig. S6 and not depicted). The observed resistance 
to experimentally applied glucocorticoids (in vitro and in vivo) 
may indicate that B cell accumulation is a consequence of the 
abnormal resistance of   bmf       /         B cells to endogenous gluco-
corticoids or related hormones. It is theoretically possible that 
Bmf loss renders B cells resistant to death stimuli that operate 
at developmental checkpoints, such as apoptosis caused by lack 
of pre  –  BCR or BCR expression. This hypothesis can best be 
analyzed by generating mice with defects in BCR gene rear-
rangement (e.g.,   rag-1       /         or   scid   mice) that also lack Bmf. 
  We have previously shown that Bmf changes its subcellu-
lar location after UV irradiation in MCF-7 cells, and there-
fore anticipated that it may play a role in the cellular response 
to UV-induced DNA damage (  23  ). However, using primary 
MEFs, we observed that loss of   bmf   did not interfere with 
cell death induced by UV irradiation. We, and others, have 
previously demonstrated that the p53-regulated BH3-only 
protein Noxa is the major rate-limiting factor in UV irradia-
tion  –  induced apoptosis of primary and   E1A/ras  -transformed 
MEFs (  38, 39  ). In contrast, cells lacking Bim, Puma, or Bad 
were all normally sensitive to UV irradiation and, remark-
ably, combined loss of Noxa and Puma did not aff  ord better 
protection than loss of Noxa alone. Interestingly, these stud-
ies also revealed that overexpression of Bcl-2 provided greater 
protection against UV than loss of Noxa, indicating that ad-
ditional BH3-only proteins may become activated in this 
process (  39  ). Although loss of Bmf alone has no eff  ect on UV 
irradiation  –  induced apoptosis (Fig. S2, A and B), it may still 
collaborate with Noxa in this cell death pathway, and in this 
regard it may be interesting to note that Bmf and Noxa have 
complimentary specifi  cities of binding to prosurvival Bcl-2 
family members (  7, 8  ). 
  Anoikis induction prevents epithelial cells from coloniz-
ing ectopic sites, and resistance to anoikis is thought to be a 
prerequisite for tumor cells to metastasize (  32  ). Expression of 
mutated Ras  V12   can prevent anoikis induction in a series of 
breast cancer cell lines and primary mammary epithelial cells. 
The molecular basis for this phenomenon appears to be the 
maintenance of Bcl-x  L   expression levels with concomitant 
suppression of the proapoptotic activity of Bak (  40, 41  ), plus JEM VOL. 205, March 17, 2008 
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  Cell death assays.     The percentage of viable cells in culture was determined 
by staining with 2   μ  g/ml PI plus FITC-coupled Annexin V (Becton Dickin-
son) and analyzing the samples in a FACScan (Becton Dickinson). Gastro-
intestinal epithelial cells were fi  xed overnight at 4  °  C in 70% ethanol and 
stained for 20 min at 37  °  C with 69   μ  M PI in 38 mM sodium citrate, pH 7.4, 
containing 5   μ  g/ml RNase A. Between 5,000 and 10,000 cells were ana-
lyzed in a FACScan. Apoptotic cells were identifi  ed within the PI-stained 
population by virtue of exhibiting an apparent subdiploid DNA content. 
  Northern blotting, Southern blotting, and PCR analysis.    PolyA  +   mRNA 
was isolated from embryonic day 14.5-derived MEFs and NIH-3T3 cells us-
ing Trizol reagent (Invitrogen) and subsequent enrichment using an mRNA 
isolation kit (QIAGEN). 3  –  4   μ  g of polyA  +   mRNA were size fractioned by 
electrophoresis on a denaturing 1% agarose-formaldehyde gel, transferred 
overnight in 10  ×   SSC onto Hybond N nylon membranes (GE Healthcare), 
UV cross-linked, baked at 80  °  C for 2 h, and probed with a   32  P-labeled mouse 
  bmf   cDNA probe (bp 1  –  558 of   bmf  ) in CHURCH buff  er over night at 65  °  C. 
Membranes were washed in 40 mM Na-phosphate buff  er containing 1% 
SDS at room temperature and exposed in a phosphorimager for 4 d. 
  To confi  rm correct targeting of ES cells and deletion of the   bmf   gene in 
tissues, 20   μ  g of total genomic DNA was digested with the appropriate re-
striction enzymes over night. Samples of DNA were size fractioned in 0.8% 
agarose gels in TAE buff  er, depurinated in 0.25 M HCl, denatured in 0.4 M 
NaOH, and transferred in the same buff  er onto Hybond N  +   nylon mem-
branes. Filters were probed with 5     and 3     external probes or a neomycin 
cassette-specifi  c probe in CHURCH buff  er at 65  °  C overnight. Membranes 
were washed in 40 mM Na-phosphate buff  er containing 1% SDS at 65  °  C 
and exposed in a phosphorimager for up to 2 d. 
  Littermates from heterozygous (  bmf  +/        ) intercrosses were genotyped by 
PCR using primer pairs specifi  c for the WT or the targeted   bmf   allele and the 
following cycle conditions: 4 min at 94  °  C; 40 s at 94  °  C, 30 s at 55  °  C, and 
60 s at 72  °  C (30 cycles); and 5 min at 72  °  C. WT allele primers: forward, 
5    -GGAGTTCAGACTTCGCCGAGAG-3    , and reverse 5    -GGCTGGT-
CACAAAGTTTGACACTG-3     (220 bp product); primers for the targeted 
allele: forward 5    -GGAGTTCAGACTTCGCCGAGAG-3     and reverse 
5    -GCAAGAGGCAAGCCCTTCACTTGG-3    . The WT and targeted   bmf   
alleles were amplifi  ed in separate reactions, yielding PCR products of 220 
and 600 bp size, respectively. 
  Immunofl   uorescence staining, fl   ow cytometric analysis, and cell 
sorting.     Single-cell suspensions from peripheral blood, bone marrow, lymph 
nodes, spleen, and thymus were surface stained with monoclonal antibodies 
conjugated with FITC, R-PE, allophycocyanin, or biotin (Invitrogen). The 
monoclonal antibodies used, and their specifi  cities, are as follows: RA3-6B2, 
anti-B220; GK1.5, anti-CD4; YTS169, anti-CD8; RB6-8C5, anti-Gr-1; 
R2/60, anti-CD43; 5.1, anti-IgM; 11/26C, anti-IgD; MI/70, anti-Mac-1; 
Ter119, anti-erythroid cell surface marker; T24.31.2, anti-Thy-1; IM7, anti-
CD44; H57-59, anti-TCR    ; anti-CD19, MB19-1 (all eBioscience); 7G6, 
anti-CD21; B3B4, anti-CD23; 281  –  2, anti-CD138 (all Becton Dickinson). 
Biotinylated antibodies were detected using streptavidin-RPE (DAKO) or 
streptavidin-vPE-Cy7 (Becton Dickinson). Flow cytometric analysis was 
performed using a FACSCalibur cell analyzer (BD Biosciences). Sorting of 
cells was performed using a FACSVantage cell sorter (Becton Dickinson). 
  Quantifi  cation of total immunoglobulin and autoantibody levels.   
  Ig-titers in the serum from 8  –  12-wk-old mice were quantifi  ed using an Ig 
clonotyping system, according to the manufacturer  ’  s instructions (Southern-
Biotech). Serum samples were used in a dilution range from 1:4,000 to 
1:160,000, depending on the isotype to secure absorbance readings in a lin-
ear range. 6  –  8-wk-old WT and   bmf       /         mice were injected i.p. with NP-
OVA (100  μ  g/mouse in CFA) to induce T cell –  dependent humoral responses 
or were injected with 10   μ  g/mouse TNP-Ficoll in PBS (Biosearch Technol-
ogies) to induce TI-2 humoral responses. Blood was collected from the 
retro-orbital plexus either before immunization or at day 7, 14, and 21 after 
immunization using a heparinized capillary, collected in an Eppendorf tube, 
mice to breed out the   cre   transgene. All analyses reported were performed 
using 376del mice and, where possible, all fi  ndings were also confi  rmed us-
ing 372del mice. 
  Cell culture and reagents.     Primary hemopoietic cells were cultured in 
RPMI 1640 medium (PAA), 250   μ  M   l-  glutamine (Invitrogen), 50   μ  M 
2-mercaptoethanol, nonessential amino acids (Invitrogen), penicillin/strepto-
mycin (Sigma-Aldrich) and 10% FCS (PAA). For the induction of cell death, 
the following reagents were used: FLAG epitope-tagged FasL (Alexis) at 
100 ng/ml, together with cross-linking M2 anti-FLAG antibody (Sigma-
Aldrich) at 1   μ  g/ml, staurosporine (Sigma-Aldrich) at 100 nM, ionomycin 
(Sigma-Aldrich) at 1   μ  g/ml, PMA at 10 ng/ml (Sigma-Aldrich), VP16 (Sigma-
Aldrich) at 1 or 10   μ  g/ml, the ER stressor tunicamycin (Sigma-Aldrich) at 
10   μ  g/ml, and the glucocorticoid dexamethasone at 10      6   or 10      7   M (Sigma-
Aldrich). Trichostatin A (Sigma-Aldrich), CBHA (Calbiochem), or SAHA 
(a gift from R. Johnstone, Peter MacCallum Cancer Center, Melbourne, 
Australia). Injections of saline, 125   μ  g dexamethasone, or 500   μ  g dexamethasone 
(Dexabene; ratiopharm) were performed i.p. in a fi  nal volume of 200   μ  l. 
  MEFs were derived from embryonic day 14.5 embryos and isolated after 
removal of internal organs, brain, and fetal liver by trypsin digestion of the re-
maining tissue. All experiments were performed using early passage (  <  5) MEFs. 
MEFs were cultured in the high-glucose version of Dulbecco  ’  s modifi  ed Eagle  ’  s 
(DME) medium supplemented with   l-  glutamine, 10% FCS, and antibiotics. 
  Isolation of primary small intestinal and colonic epithelial cells.   
  Complete small intestine and colon were dissected from mice, freed from 
residual feces and mucus after longitudinal section, and transferred into ice-
cold HBSS without Ca  2+   and Mg  2+  . After rinsing several times in HBSS 
(Invitrogen) at room temperature, residues were shaken gently in 15 ml of 
HBSS containing 2 mM EDTA, pH 8.0, for 30 min at 37  °  C. The solid 
material was transferred to a new 50-ml tube, and the supernatant was 
discarded. The remaining mucosa was vortexed in 10 ml PBS, and the super-
natant containing complete crypts and some single cells was collected into 
a fresh 15-ml tube containing PBS. Vortexing was repeated until the super-
natant was almost clear. To separate remaining crypts from single cells, crypts 
were allowed to settle down for up to 5 min at room temperature, and single 
cells were transferred by carefully pipetting the supernatant into a new 15-ml 
tube and collected by centrifugation at 1,500 rpm for 5 min at room 
temperature. After washing with PBS, the cells were resuspended in keratino-
cyte serum  –  free medium (KFS) supplemented with EGF and BPE (Invitro-
gen). To induce anoikis, cells were transferred to a low adherence 6-well 
plate and incubated at 37  °  C for the indicated time. Cell viability was assessed 
by intracellular DNA content analysis in a FACScan (BD Biosciences), as 
described in Cell death assays. 
  Immunoblotting.     Western blotting was performed as previously described 
(  47  ). Membranes were probed with rabbit anti-Puma antiserum (Cell Sig-
naling Technology), monoclonal antibodies to Bad (Cell Signaling Technol-
ogy), active caspase-3 (Cell Signaling Technology), rat anti  –  mouse Bmf 
mAb (17A9) or rat anti  –  mouse, rat, human, monkey, dog Bim (3C5), gener-
ated at the WEHI and now commercially available from Alexis. Equal load-
ing of proteins was confi  rmed by probing fi  lters with antibodies specifi  c for 
    -actin (Sigma-Aldrich) or ERK1/2 (Cell Signaling Technology). Horse-
radish peroxidase  –  conjugated sheep anti  –  rat Ig antibodies (Jackson Immuno-
Research Laboratories) or goat anti  –  rabbit antibodies (DAKO) served as 
secondary reagents, and the enhanced chemiluminescence (GE Healthcare) 
system was used for detection. 
  BrdU staining.     BrdU (Roche) was injected i.p. (1 mg/mouse in 200   μ  l sa-
line) 4 h before sacrifi  ce of the animals. BrdU incorporation was quantifi  ed 
according to the recommendations of the BrdU Flow kit staining protocol 
(Becton Dickinson) using a FITC-labeled anti-BrdU mAb (Roche) in com-
bination with fl  uorochrome-conjugated antibodies against CD4, CD8, 
Thy1, CD19, IgM, and CD43. Thymocytes from untreated mice were rou-
tinely included in the analysis and served as a negative control. 654 BMF IS REQUIRED FOR NORMAL B CELL HOMEOSTASIS | Labi et al.
in response to diff  erent mitogens. The online version of this article is avail-
able at http://www.jem.org/cgi/content/full/jem.20071658/DC1. 
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and incubated for 2  –  3 h at 37  °  C. The samples were centrifuged, and serum 
was obtained and stored at     80  °  C. To determine antibody titers against 
4-hydroxy-3-nitrophenylacetyl (NP) and 2,4,6-trinitrophenyl (TNP) the 
respective antigen conjugated to BSA (Biosearch Technologies) was coated 
on ELISA plates. ELISAs were performed as described (  16  ). Serum samples 
were used in a dilution range from 1:800 to 1:1,600. To detect anti-ds 
DNA-specifi  c antibodies, calf thymus DNA (Sigma-Aldrich) in distilled 
water. (12.5   μ  g/ml) was allowed to bind overnight to 96-well ELISA 
plates (Corning Costar) precoated for 1 h at 37  °  C with poly-L-lysine (0.1% 
in distilled water). For anti-dsDNA autoantibody detection, a horseradish 
peroxidase  –  labeled goat anti  –  mouse IgH + L-specifi  c antibody and ABTS as 
a substrate were used (Souther Biotech). Mouse sera were diluted 1:100 in 
PBS/BSA1%. Serum derived from autoimmune prone NZW/NZW F1 
mice was used as a positive control. 
  Cell proliferation assays.     FACS-sorted splenic B cells (10  5  /well) were 
cultured in the presence of saturating concentrations of IL-2, -4, and -5 (all 
from PeproTech) without further treatment or were stimulated with 2   μ  g/ml 
goat anti  –  mouse IgM F(ab  ´  )  2   fragments (Jackson ImmunoResearch Labora-
tories), 20   μ  g/ml LPS (Sigma-Aldrich), 2   μ  g/ml hamster anti  –  mouse CD40 
mAb (HM40-3; BD), or 100 nM of ODN74, a CpG motif containing oligo-
deoxynucleotide (5    -AAAAAAAAAAAAAACGTTAAAAAAAAAAA-3    ). 
Cells were pulsed for 18 h with 1   μ  Ci/well [  3  H]thymidine (GE Healthcare) 
at day 2 and 4, respectively. Alternatively, cells were labeled with CFSE 
(Invitrogen) at day 0, and loss of fl  uorescence intensity was assessed by fl  ow 
cytometry after 48 or 72 h in culture in the absence or presence of mito-
gens. In brief, total splenic B cells, isolated by negative FACS sorting, were 
washed twice in PBS and incubated in 5   μ  M CFSE/PBS solution for 10 min 
at 37  °  C. Cells were washed immediately three times in excess PBS and put 
in culture. FACS-sorted pre  –  B cells derived from bone marrow (10  5  /well) 
were cultured in the absence or presence of graded doses of IL-7 (PeproTech), 
and proliferation was monitored by FACS analysis quantifying changes in 
cell size in the FSC profi  le over time. 
  Competitive hemopoietic reconstitution assays.     C57BL/6 Ly5.1 coiso-
genic animals were purchased from Charles River Laboratories and exposed 
to a single dose of      irradiation (10Gy). Mice were reconstituted i.v. 6 h later 
using a 50:50 mixture of WT Ly5.1 + WT Ly5.2 or WT Ly5.1 +   bmf       /       
  Ly5.2 bone marrow cells (total 4   ×   10  6   cells/mouse). Treated mice received 
2 mg/ml neomycine in the drinking water for 4 wk after reconstitution to 
minimize the risk of infection. Reconstitution was monitored in peripheral 
blood samples over time by FACS analysis using a Ly5.2-specifi  c antibody ei-
ther alone or in combination with antibodies to CD4, CD8, or CD19. 
  Preparation of histological sections.     Organs were fi  xed in 4% parafor-
maldehyde in PBS, processed according to standard procedures, and stained 
in hematoxylin and eosin. 
  Statistical analysis.     Statistical analysis was performed using the unpaired 
Student  ’  s   t   test or analysis of variance analysis, where indicated, and applying 
the Stat-view 4.1 software program. P values of   <  0.05 were considered to 
indicate statistically signifi  cant diff  erences. 
  Online supplemental material.     Fig. S1 shows that loss of Bmf does not 
generally impair apoptosis of lymphocytes induced by HDAC inhibitors, nor 
does loss of Bmf impair apoptosis of B220  +   splenic B cells in response to 
cytokine deprivation, dexamethasone treatment, or BCR ligation. Fig. S2 
shows that Bmf-defi  cient mice mount normal immune responses to T cell  –
  dependent and   –  independent antigens. Fig. S3 demonstrates that apoptosis 
induced by UV irradiation or loss of attachment is not impaired in   bmf       /         
MEFs. Fig. S4 demonstrates that anoikis in gastrointestinal epithelial cells is 
not impaired in the absence of   bim   or   bmf  . Fig. S5 shows cell surface ex-
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